S
Sana Biotechnology, Inc.
SANA · NASDAQ · Healthcare · 988M
Closing price
$2.79
+0.00% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.4×
Enterprise value / EBITDAEV/EBITDA
-3.1×
Free cash flow yieldFCF yield
-20.5%
Return on equityROE
-151.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.